Log In
Print this Print this

moxifloxacin (Moxeza)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionNew formulation of Vigamox moxifloxacin hydrochloride ophthalmic solution
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationConjunctivitis
Indication DetailsTreat bacterial conjunctivitis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today